Generate a tailored SOP for Dr. Signe Borgquist. Improve your application with a focused, well-structured draft.
Signe Borgquist is a medical oncologist and associate professor at Lund University, where she spearheads a translational research group focused on Breast Cancer Prevention and Intervention within the Division of Oncology Pathology at the Department of Clinical Sciences. She works as a senior consultant at the Trial Unit of Skåne University Hospital in Lund. Her scientific interests are centered around breast cancer risk estimation and prevention, with a dedicated focus on obesity-associated markers and the functional interactions of adipocytes and lipids with cancer cells. Borgquist's work is aligned with the UN Sustainable Development Goals, specifically addressing global health and wellbeing. She is actively involved in various research projects, including the PROTECT study aimed at early detection of breast cancer initiation. Moreover, she is a part of the International Ki67 Breast Cancer Working Group, contributing her expertise in consultancy and expert advice. Borgquist's contributions are essential in advancing knowledge and strategies for breast cancer risk management and prevention.
Lund University • Lund, Sweden
Head of translational research group focusing on breast cancer.
Skåne University Hospital • Lund, Sweden
Working in the Trial Unit specializing in medical oncology.
Includes Master of Science in Politics and Society of the Contemporary Middle East and European Affairs.